
    
      This is a Phase 2, multicentre, randomised, double-blind, placebo-controlled study to
      evaluate the Safety, Pharmacokinetics and Efficacy of four oral treatment regimens of DHA
      versus placebo while taking standard of care (SOC) treatment with corticosteroids in adult
      subjects with Systemic Lupus Erythematosus (SLE).
    
  